Yahoo España Búsqueda web

Search results

  1. Other activities / non-profit activities / memberships. Since 2009 Member of the International Business Leaders Advisory Council for the Mayor of Shanghai (IBLAC), Vice Chairman from 2022 - 2023, since 2024 Chairman. Since 2023 Member of the European Round Table for Industry - ERT.

    • Team & Structure

      A unique structure and our diverse mix of autonomous...

    • Strategy

      Zur deutschen Version. Healthcare is undergoing tremendous...

    • Solutions

      Since the founding of our company, we have been developing...

    • Investors

      We are committed to delivering value for all our...

  2. Severin Anton Schwan (born November 17, 1967) is an Austrian business executive. He is the current chairman of the board and former CEO (2008–2023) of the Roche Group. Schwan joined the Roche Group in 1993 as a trainee and has stayed with the company ever since.

  3. 21 de jul. de 2022 · Roche’s chief executive Severin Schwan will step down next March and has been nominated as chair, after 15 years at the helm of one of the world’s biggest drugmakers by revenue. Schwan will be...

  4. Severin Schwan habla sobre nuestra larga trayectoria de sostenibilidad y el estado de la humanidad. Durante meses, millones de jóvenes han salido a las calles para protestar contra la crisis climática. ¿Cómo te sientes al respecto? Me complace que el tema esté cobrando impulso ahora.

  5. El Consejo de Administración de Roche propondrá a Severin Schwan como nuevo presidente en la Asamblea General Anual del 14 de marzo de 2023. Severin Schwan ha sido miembro del Comité Ejecutivo Corporativo desde 2006 y se ha desempeñado como director ejecutivo de la empresa desde 2008.

  6. 24 de abr. de 2020 · Severin Schwan unapologetic for outspoken criticism of state responses to coronavirus. Severin Schwan has developed a reputation for being a solid helmsman, taking his pharma group’s revenues...

  7. 21 de jul. de 2022 · Departing boss presided over Roche-Genentech tie-up and steered the company through patent expiries. Roche CEO Severin Schwan is due to step down in March. Photo: Simon Dawson/Bloomberg News.